A5101567123- Inflammatory Bowel Disease
- Medication Adherence and Compliance
- Adolescent and Pediatric Healthcare
- Systemic Sclerosis and Related Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Eosinophilic Esophagitis
- Metabolism and Genetic Disorders
- Immune Cell Function and Interaction
- LGBTQ Health, Identity, and Policy
- T-cell and B-cell Immunology
- Mobile Health and mHealth Applications
- Pharmaceutical studies and practices
- Gender, Feminism, and Media
- Stoma care and complications
- Behavioral Health and Interventions
- Telemedicine and Telehealth Implementation
- Enhanced Recovery After Surgery
- Epilepsy research and treatment
- Psychiatric care and mental health services
- COVID-19 and healthcare impacts
- Bipolar Disorder and Treatment
- Neuroscience and Neuropharmacology Research
- Gender Roles and Identity Studies
- Celiac Disease Research and Management
- Mental Health Treatment and Access
McGill University
2002-2024
University of California, Los Angeles
2019-2023
Olive View-UCLA Medical Center
2023
University of Minnesota
2022
A common T17A polymorphism in the signal peptide of cytotoxic T-lymphocyte antigen 4 (CTLA-4), a T-cell receptor that negatively regulates immune responses, is associated with risk for autoimmune disease. Because absent from mature protein, we hypothesized its biological effect must involve early stages protein processing, prior to cleavage. Constructs representing two alleles were compared byin vitro translation, presence endoplasmic reticulum membranes. We studied glycosylation by...
Rising healthcare expenditures have been partially attributed to suboptimal management of inflammatory bowel diseases (IBD). Electronic health interventions may help improve care for IBD patients, but there is a need better understand patient perspectives on these emerging technologies.The primary aim was evaluate satisfaction and experience with the UCLA eIBD mobile application, an integrative platform disease activity monitoring tools educational modules. The secondary objective capture...
There are little published data on the transition of care in EB. We conducted a survey study recruiting EB patients from Dystrophic Research Association (debra) website and centers caring for high numbers United States internationally Sept 17, 2019 to Nov 3, 2021. The majority participants had not discussed with their healthcare providers, nor needs be required as an adult. Ongoing pediatric subspecialty was reported by 12% adults, most commonly dermatology. Identified barriers included...
Background:Despite advancements in treatment for inflammatory bowel disease (IBD), surgery remains inevitable patients and IBD management is costly. Introduction:Frequent postoperative monitoring needed early detection of both short-term complications long-term recurrence. We developed a care pathway home using telehealth applications. Materials Methods:We performed retrospective cohort study with matched control group to assess the efficacy Tight Control Surgery Scenario (TCSS), 4-week...
PCDH19 (OMIM 300460) pathogenic variants are associated with a range of neurodevelopmental abnormalities and epilepsy.1, 2 This X-linked condition has been referred to as "girls clustering epilepsy," the classical phenotype involving infantile onset recurrent seizure clusters, sometimes lasting several days, in context febrile illnesses.3-5 Seizure semiology is focal vast majority, motor described 85%. Non-motor seizures reported 59%, features including behavioral arrest, loss tone,...
Few institutions have integrated psychologists into consult-liaison (CL) psychiatry services caring for patients with medical conditions and comorbid serious mental illnesses (SMI). To our knowledge, no studies explored the experiences of an pre-doctoral psychologist on a CL service applications collaborative care. The present study aims to 1) highlight psychology extern adult in public academic hospital, 2) apply care framework provide recommendations implementing psychiatry-psychology...
Abstract Background Medication nonadherence is a challenge in chronic disease management. Tools that can both determine adherence levels and analyze patient-specific reasons for are lacking. Methods Our tool was developed using 23 patient-reported items its predictive performance compared with the most widely used instrument literature. Results One hundred thirty-three IBD patients were included, 44 (33%) nonadherent 89 (67%) adherent. screening question, 87% sensitivity 64% specificity,...
Medication nonadherence is a significant challenge in inflammatory bowel diseases (IBD), and associated with high costs negative outcomes. The vast majority of studies report IBD the range 30–45%. With increased adaptation electronic health (e-health) technologies, there opportunity to monitor patient adherence behaviours remotely. However, no tool exists that can both determine levels quantify patient-specific reasons for nonadherence. We developed medication index categorise assess factors...